Abbreviations AD: Alzheimers disease BBB: bloodbrain barrier GLP-1: glucagon-like peptide-1 GLP-1R(s): GLP-1 receptor(s) GLP-1RA(s): GLP-1 receptor agonists NDD: neurodegenerative diseases PD: Parkinsons disease T2DM: type 2 diabetes mellitus REFERENCES Knudsen LB, Lau J (2019) The Discovery and Development of Liraglutide and Semaglutide
Sign in here Free access to our premium content: Clinical content In-depth analysis Features, reports, videos and more By joining, youre helping to support independent, quality journalism that keeps dental professionals informed and empowered and allowing us to keep delivering the insights you value most.
Not for human or animal consumption, clinical, therapeutic, cosmetic, or veterinary use
Furthermore, regarding the mechanisms of GLP-1 secretion regulation in intestinal L-cells, including the potentiation mechanism of the main pathway, many unresolved aspects remain to be elucidated
Fitness isnt a chore anymore its something I love